Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
C4 Imaging develops the SIRIUS MRI Marker, a device for precise localization of implanted LDR seeds in MRI imaging to support post-implant quality assurance in brachytherapy treatments. The product helps ensure accurate treatment delivery and protects critical anatomical structures during radiation therapy procedures.
0 investors
Cadrenal Therapeutics is a clinical-stage biopharmaceutical company developing anticoagulation and antithrombotic therapies for cardiovascular and thrombotic disorders. Its pipeline includes CAD-1005, a first-in-class 12-LOX inhibitor for heparin-induced thrombocytopenia, tecarfarin for end-stage kidney disease and LVAD patients, and frunexian, an intravenous Factor XIa inhibitor for acute/critical care settings.</parameter> <parameter name="founders">[]
0 investors
0 investors
CAGE Bio is a clinical-stage biotech developing localized topical treatments for dermatology, inflammation, and immunology conditions using its proprietary deep eutectic ionic liquid platform. The technology enables small and large molecules such as proteins and nucleic acids to penetrate the skin, aiming to match the efficacy of systemic drugs while avoiding their side effects.
0 investors
0 investors
Cairn Therapeutics is a biopharmaceutical company developing oncology treatments intended to address drawbacks of standard chemotherapy such as side effects, low potency, and multidrug resistance. Its lead candidate, CT-262, is based on duocarmycin drug chemistry invented by Dale Boger at Scripps Research.
0 investors
Cajal Therapeutics is a biotech company developing novel therapies through the translation of neuroscience research into therapeutic treatments for patients.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Calidi is a biotech company developing genetic medicine therapies. The page describes it as a biotech startup working in the genetic medicine field.
0 investors
A company building pharmacy infrastructure to support modern medicine, currently pre-launch. The page provides no further detail on its product or customers.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Cambridge Technologies provides veterinarians with next-generation diagnostics and custom-manufactured autogenous vaccines for production animals, including beef and dairy cattle, swine, and small ruminants. Using its "Precision Vaccinology" process, the company sequences herd samples to identify pathogens and formulates herd-specific vaccines to prevent disease and reduce antibiotic dependence.
0 investors